

Learn how Orilissa works in plain English. Understand its mechanism of action, how it reduces endometriosis pain, and how it compares to similar medications.
Orilissa works by blocking the hormone signal that tells your body to produce estrogen — and less estrogen means less fuel for endometriosis pain.
Think of your body's hormone system like a chain of messages. Your brain sends a signal (GnRH) to the pituitary gland, which tells your ovaries to make estrogen. Estrogen then feeds the endometrial tissue — including the tissue that's growing where it shouldn't be, causing your endometriosis pain.
Orilissa (Elagolix) works by blocking the receiver for that brain signal. It sits on the GnRH receptors in your pituitary gland like a key stuck in a lock — preventing the real key (GnRH) from turning on estrogen production. The result: your estrogen levels drop, and the endometrial tissue shrinks and becomes less active, which reduces pain.
This is why Orilissa is called a GnRH antagonist — it antagonizes (blocks) the GnRH receptor.
One of Orilissa's unique features is that its estrogen-lowering effect is dose-dependent:
This dose flexibility is something older GnRH treatments didn't offer. Your doctor can tailor the dose to balance pain relief against side effects.
Most women begin to notice improvement in endometriosis pain within the first month of treatment. In clinical trials, statistically significant pain reduction was seen as early as Month 1 for both the 150 mg and 200 mg doses.
However, the full effect builds over time. Many patients experience continued improvement through the first two to three months. If you're not noticing any benefit after two to three months, talk to your doctor about whether the dose needs to be adjusted or whether a different treatment might work better.
Orilissa has a relatively short half-life of about 4 to 6 hours. This means the drug is mostly cleared from your system within a day of your last dose. This is actually an advantage — if you experience side effects, they tend to improve quickly once you stop taking it.
After stopping Orilissa:
Lupron is a GnRH agonist, while Orilissa is a GnRH antagonist. Here's the key difference:
Other differences:
Myfembree is a newer oral GnRH antagonist that combines Relugolix with estradiol and norethindrone (hormonal "add-back" therapy). The add-back hormones are included to reduce bone loss and hot flashes.
For a full comparison of treatment options, see Alternatives to Orilissa.
Hormonal birth control (pills, patches, IUDs) is often the first-line treatment for endometriosis. These work by stabilizing or suppressing hormone fluctuations, but they don't specifically target the GnRH pathway like Orilissa does.
Orilissa is typically tried when hormonal birth control hasn't provided enough pain relief, or when a patient can't take hormonal contraceptives.
Knowing how Orilissa works helps you understand:
Orilissa works by intercepting the hormonal signal that drives endometriosis pain. It blocks GnRH receptors in the pituitary gland, reducing estrogen production and calming the endometrial tissue causing your symptoms. Its dose-dependent approach gives doctors flexibility to balance pain relief with side effects — something that wasn't possible with older GnRH treatments like Lupron.
If you think Orilissa might be right for you, talk to your doctor. For help finding a prescriber, check out our guide on how to find a doctor who can prescribe Orilissa. Already have a prescription? Search Medfinder to find it in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.